Holen Sie sich die Stockscreener-App
255.37
2.45%
6.11
Handel nachbörslich:
255.19
-0.18
-0.07%
Schlusskurs vom Vortag:
$249.26
Offen:
$251.51
24-Stunden-Volumen:
39,878
Relative Volume:
0.67
Marktkapitalisierung:
$3.19B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.45%
1M Leistung:
+18.85%
6M Leistung:
+22.94%
1J Leistung:
+55.95%
1-Tages-Spanne:
$251.34
$255.39
1-Wochen-Bereich:
$242.08
$255.39
52-Wochen-Spanne:
$158.92
$255.39
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Company Profile
Firmenname
First Trust Nyse Arca Biotechnology Index Fund
Sektor
Branche
Telefon
-
Adresse
-
Compare FBT vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBT
First Trust Nyse Arca Biotechnology Index Fund
|
255.37 | 3.19B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
368.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
744.78 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
748.43 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.34 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
712.60 | 124.43B | 0 | 0 | 0 | 0.00 |
First Trust Nyse Arca Biotechnology Index Fund Aktie (FBT) Neueste Nachrichten
Price-Driven Insight from (FBT) for Rule-Based Strategy - Stock Traders Daily
First Trust NYSE Arca Biotechnology Index Fund (FBT) Stock Price Quote Today & Current Price Chart - Capital.com
Why Is Natera Stock Gaining Tuesday? - Sahm
Genmab A/S (GMAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
United Therapeutics Corp (UTHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waters Corp (WAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biontech SE (BNTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moderna Inc (MRNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Exact Sciences Corp (EXAS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vertex Pharmaceuticals Inc (VRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mettler-Toledo International Inc (MTD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Natera Inc (NTRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioMarin Pharmaceutical Inc (BMRN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ACADIA Pharmaceuticals Inc (ACAD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Regeneron Pharmaceuticals Inc (REGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Krystal Biotech Inc (KRYS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Repligen Corp (RGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alkermes Plc (ALKS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Neurocrine Biosciences Inc (NBIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
argenx SE (ARGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biogen Inc (BIIB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Incyte Corp (INCY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Exelixis Inc (EXEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beigene Ltd (ONC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bruker Corp (BRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Halozyme Therapeutics Inc (HALO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
(FBT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - AOL.com
Investors Evaluate FBT and XPH for Strategic Healthcare Exposure - asatunews.co.id
State Street vs First Trust: Comparing Two Healthcare ETFs - IndexBox
SPDR S&P Pharmaceuticals and First Trust NYSE Arca Biotech ETFs Offer Distinct Healthcare Paths - sekbernews.id
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - The Motley Fool
(FBT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
5 Biggest Biotechnology ETFs in 2026 - Investing News Network
(FBT) Risk Channels and Responsive Allocation - Stock Traders Daily
(FBT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Should you invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - MSN
Is First Trust NYSE Arca Biotechnology ETF (FBT) a strong ETF right now? - MSN
EDGAR Filing Documents for 0001445546-23-002834 - SEC.gov
EDGAR Filing Documents for 0001445546-18-002120 - SEC.gov
EDGAR Filing Documents for 0001445546-20-002174 - SEC.gov
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
Liquidity Mapping Around (FBT) Price Events - Stock Traders Daily
Moderna's Legal Hit Steals Spotlight From Strong Sales - Sahm
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Why (FBT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
First Trust NYSE Arca Biotechnology Index Fund (FBT) - Minichart
Mix-And-Match Sector Fund Boosts Performance - Stock Investor
Finanzdaten der First Trust Nyse Arca Biotechnology Index Fund-Aktie (FBT)
Es liegen keine Finanzdaten für First Trust Nyse Arca Biotechnology Index Fund (FBT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):